PAR-17-003: Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01) [Learn more]
RFA-CA-17-005: Cancer Immune Monitoring and Analysis Centers (CIMACs) (U24) [Learn more]
RFA-CA-17-006: Cancer Immunologic Data Commons (CIDC) (U24) [Learn more]
New Version of Biospecimen Research Database Available!
The BRD is a free and publicly accessible literature database that contains peer-reviewed primary and review articles in the field of human Biospecimen Science. New features include a dynamic homepage, enhanced search options (such as keyword search), and user commenting.
Upcoming Webinar, July 27th: Diverse Patient Values About a 'Library
of Medical Information': EHRs and Biospecimens in Research
Visit the ENRICH forum website for information and to register
Welcome to the Cancer Diagnosis Program!
The Cancer Diagnosis Program strives to improve the diagnosis and assessment of cancer by effectively moving new scientific knowledge into clinical practice. This national program stimulates, coordinates and funds resources and research for the development of innovative in vitro diagnostics, novel diagnostic technologies and appropriate human specimens in order to better characterize cancers and allow improved medical decision making and evaluation of response to treatment.
For more information about the Cancer Diagnosis Program and its Branches, please click here.
Sign up for Email Updates
Follow us on Twitter
Contact Us